Cargando…
Toward personalized TGFβ inhibition for pancreatic cancer
Cancer can be conceptualized as arising from somatic mutations resulting in a single renegade cell escaping from the constraints of multicellularity. Thus, the era of precision medicine has led to intense focus on the cancer cell to target these mutations that result in oncogenic signaling and susta...
Autores principales: | Carr, Ryan M, Fernandez‐Zapico, Martin E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835199/ https://www.ncbi.nlm.nih.gov/pubmed/31639254 http://dx.doi.org/10.15252/emmm.201911414 |
Ejemplares similares
-
PI3Kα targeting, nipping pancreatic cancer evolution in the bud
por: Raja Arul, Glancis Luzeena, et al.
Publicado: (2021) -
Patient‐derived organoids, creating a new window of opportunities for pancreatic cancer patients
por: Sandhya, Sandhya, et al.
Publicado: (2022) -
Improved MHC II epitope prediction — a step towards personalized medicine
por: Moore, Tamson V., et al.
Publicado: (2019) -
Person-centered health education and training
por: Braš, Marijana, et al.
Publicado: (2014) -
A novel empeROR of pancreatic malignancy
por: Peñuelas‐Haro, Irene, et al.
Publicado: (2023)